Efficacy and Safety of Ixekizumab with or Without Methotrexate in Biologic-Naïve Patients with Psoriatic Arthritis: 52-Week Results from SPIRIT-H2H Study

  • Josef S. Smolen (Creator)
  • Anthony I. Sebba (Creator)
  • Eric M Ruderman (Creator)
  • Hendrik Schulze-Koops (Creator)
  • Christophe Sapin (Creator)
  • Amanda M. Gellett (Creator)
  • Aubrey Trevelin Sprabery (Creator)
  • L. Li (Contributor)
  • Inmaculada de la Torre (Contributor)
  • G. Gallo (Creator)
  • Soyi Liu-Leage (Contributor)
  • Sreekumar Pillai (Contributor)
  • Paulo Reis (Creator)
  • Peter Nash (Creator)



Article full text The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days. The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2020.
Date made available2020
PublisherAdis Journals

Cite this